HELX Among Health Care ETFs
End-of-day Nov 20, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.6% | −6.4% | −6.8% | −6.1% | +9.5% | +12.0% | +46.5% | −20.4% | — | +67.2% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$86 of every $1,000 in HELX is Guardant
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GHGuardant Health | Healthcare | 8.63% | $862.69 | 19K | $2.8M |
| 2 | NTRANatera | Healthcare | 7.79% | $779.26 | 8,775 | $2.5M |
| 3 | KRYSKrystal Biotech | Healthcare | 5.26% | $525.77 | 5,435 | $1.7M |
| 4 | ADPTAdaptive Biotechnologies | Healthcare | 5.10% | $510.17 | 59K | $1.7M |
| 5 | LGNDLigand Pharmaceuticals | Healthcare | 4.47% | $446.93 | 5,085 | $1.5M |
| 6 | BBIOBridgebio Pharma | Healthcare | 3.59% | $359.28 | 15K | $1.2M |
| 7 | TWSTTwist Bioscience | Healthcare | 3.31% | $330.72 | 9,673 | $1.1M |
| 8 | MEDPMedpace | Healthcare | 2.93% | $293.04 | 1,509 | $957K |
| 9 | LLYELI Lilly | Healthcare | 2.83% | $283.49 | 685 | $926K |
| 10 | VRTXVertex Pharmaceuticals IN | Healthcare | 2.81% | $281.49 | 1,765 | $919K |
| 11 | UTHRUnited Therapeutics | Healthcare | 2.80% | $279.83 | 1,634 | $914K |
| 12 | REGNRegeneron Pharmaceuticals | Healthcare | 2.60% | $259.65 | 919 | $848K |
| 13 | TVTXTravere Therapeutics | Healthcare | 2.39% | $239.13 | 16K | $781K |
| 14 | VYLRVylor | Basic Materials | 2.17% | $216.99 | 10K | $708K |
| 15 | CDNACaredx | Healthcare | 2.01% | $201.39 | 9,142 | $657K |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GH | Guardant Health | 8.63% |
| 2 | NTRA | Natera | 7.79% |
| 3 | KRYS | Krystal Biotech | 5.26% |
| 4 | ADPT | Adaptive Biotechnologies | 5.10% |
| 5 | LGND | Ligand Pharmaceuticals | 4.47% |
| 6 | BBIO | Bridgebio Pharma | 3.59% |
| 7 | TWST | Twist Bioscience | 3.31% |
| 8 | MEDP | Medpace | 2.93% |
| 9 | LLY | ELI Lilly & | 2.83% |
| 10 | VRTX | Vertex Pharmaceuticals IN | 2.81% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Jan 8, 2026 | $0.14 |
| Dec 30, 2021 | Jan 7, 2022 | $0.0039 |
| Dec 13, 2021 | Dec 21, 2021 | $0.11 |
| Dec 14, 2020 | Dec 23, 2020 | $0.0520 |